STOCK TITAN
The best stock market news and trading tools all in one place—your must-have platform for investing success.
A must-have platform for stock market information, offering the best tools and updates to supercharge your trading.
Your trusted source for the best stock market news, trading tools, and expert advice. Everything traders need, in one place.

Yield10 Bioscience to Participate at the Benzinga Global Small Cap Conference on May 14, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Yield10 Bioscience, an agricultural bioscience company, will participate in the Benzinga Global Small Cap Conference on May 14, 2021. CEO Oliver Peoples will be featured in a "Fireside Chat" on the Disruptive Innovation track from 12:10 to 12:25 PM EDT. Additionally, he will hold one-on-one meetings with registered investors. An archived replay of the discussion will be available on the conference website. Yield10 focuses on developing superior Camelina varieties and aims to commercialize valuable genetic traits for agriculture.

Positive
  • None.
Negative
  • None.

WOBURN, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced that management will participate at the Benzinga Global Small Cap Conference on May 14, 2021.

President and Chief Executive Officer Oliver Peoples, Ph.D. will participate in a “Fireside Chat” session on the Disruptive Innovation track slated for 12:10 pm to 12:25 pm EDT on Friday, May 14, 2021. Dr. Peoples will also be available to participate in one-on-one meetings with investors who are registered to attend the conference. An archived replay of the presentation will be available via the conference website.

Investors can register for the conference here:
https://www.benzinga.com/events/small-cap/global/

About Yield10 Bioscience

Yield10 Bioscience, Inc. is an agricultural bioscience company that is using its differentiated trait gene discovery platform, the “Trait Factory”, to develop improved Camelina varieties for the production of proprietary seed products, and to discover high valuable genetic traits for the agriculture and food industries. Our goals are to efficiently establish a high value seed products business based on developing superior varieties of Camelina for the production of feedstock oils, nutritional oils, and PHA bioplastics, and to license our yield traits to major seed companies for commercialization in major row crops, including corn, soybean and canola. Yield10 is headquartered in Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon, Canada.

For more information about the company, please visit www.yield10bio.com, or follow the Company on Twitter, Facebook and LinkedIn.

Contacts:
Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com

Investor Relations:
Bret Shapiro, (561) 479-8566, brets@coreir.com
Managing Director, CORE IR

Media Inquiries:
Eric Fischgrund, eric@fischtankpr.com
FischTank PR


FAQ

What will Yield10 Bioscience present at the Benzinga Global Small Cap Conference?

Yield10 Bioscience will present a 'Fireside Chat' with CEO Oliver Peoples on May 14, 2021, highlighting their agricultural innovations.

When is the Yield10 Bioscience presentation scheduled?

The presentation is scheduled for May 14, 2021, from 12:10 PM to 12:25 PM EDT.

How can investors register for the Benzinga Global Small Cap Conference?

Investors can register for the conference by visiting the Benzinga website.

What is the focus of Yield10 Bioscience's business model?

Yield10 Bioscience focuses on developing improved Camelina varieties and commercializing genetic traits for the agriculture sector.

Who is the CEO of Yield10 Bioscience?

The CEO of Yield10 Bioscience is Oliver Peoples, Ph.D.

YIELD10 BISCIENCE INC NEW

OTC:YTEN

YTEN Rankings

YTEN Latest News

YTEN Stock Data

1.52M
567.28k
17.55%
0.03%
0.39%
Agricultural Inputs
Basic Materials
Link
United States of America
WOBURN